Tag: M.W:100-200

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 13940-83-5, is researched, Molecular F2H8NiO4, about Synthesis of anhydrous nickel and cobalt fluorides, the main research direction is fluoride cobalt nickel preparation; carbonate cobalt nickel basic fluorination; fluorocobaltate ammonium; fluoronickelate ammonium.Computed Properties of F2H8NiO4.

The optimum conditions were determined for the reaction of M2(OH)2CO3 (M = Co, Ni) or MF2.4H2O with NH4F or (NH4)HF2 at 240° to give (NH4)2MF4 which decomposed at ∼400° to MF2. The reaction products were identified by IR spectra and x-ray diffraction.

As far as I know, this compound(13940-83-5)Computed Properties of F2H8NiO4 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: 8-Hydroxyquinoline 1-oxide(SMILESS: OC1=CC=CC2=CC=C[N+]([O-])=C12,cas:1127-45-3) is researched.Computed Properties of F2H8NiO4. The article 《Synthesis of a new chiral selector base on pracoterol for chiral stationary phase》 in relation to this compound, is published in Advanced Materials Research (Durnten-Zurich, Switzerland). Let’s take a look at the latest research on this compound (cas:1127-45-3).

According to the chiral resolution mechanism and structures of Pirkle’s chiral stationary phase (CSP), a new amide chiral selector base on pracoterol was prepared in this thesis. To get a better yield, all the conditions and purification conditions of the reactions were studied, and the key products were characterized by HPLC, FTIR and 1H NMR. This chiral selector may be developed as chiral selector of CSP.

As far as I know, this compound(1127-45-3)Formula: C9H7NO2 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Quality Control of 8-Hydroxyquinoline 1-oxide. The protonation of heteroatoms in aromatic heterocycles can be divided into two categories: lone pairs of electrons are in the aromatic ring conjugated system; and lone pairs of electrons do not participate. Compound: 8-Hydroxyquinoline 1-oxide, is researched, Molecular C9H7NO2, CAS is 1127-45-3, about The oxidation of pyridines catalyzed by surfactant-encapsulated polyoxometalate [(C18H37)2(CH3)2N]8[HBW11O39] with the temperature-responsive property of solubility. Author is Zhao, Wei; Yang, Chunxia; Ding, Yong; Ma, Baochun.

Temperature-responsive characterization of solubility based on a surfactant-encapsulated polyoxometalate ([(C18H37)2(CH3)2N]8[HBW11O39]) in tert-Bu alc. was described and used in catalytic oxidation of pyridines. The catalyst could be recovered and reused several times by controlling the temperature

As far as I know, this compound(1127-45-3)Quality Control of 8-Hydroxyquinoline 1-oxide can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Heterocyclic compounds can be divided into two categories: alicyclic heterocycles and aromatic heterocycles. Compounds whose heterocycles in the molecular skeleton cannot reflect aromaticity are called alicyclic heterocyclic compounds. Compound: 57825-30-6, is researched, Molecular C9H11Br, about Discovery of Orally Available Runt-Related Transcription Factor 3 (RUNX3) Modulators for Anticancer Chemotherapy by Epigenetic Activation and Protein Stabilization, the main research direction is pyridinone acrylate preparation runt related transcription factor modulator antitumor.Application of 57825-30-6.

Recently, the authors identified a novel strategy for anticancer chemotherapy by restoring runt-related transcription factor 3 (RUNX3) levels via lactam-based histone deacetylase (HDAC) inhibitors that stabilize RUNX3. Described here are the synthesis, biol. evaluation, and pharmacokinetic evaluation of new synthetic small mols. based on pyridone-based HDAC inhibitors that specifically stabilize RUNX3 by acetylation and regulate its function. Many of the newly synthesized compounds showed favorable RUNX activities, HDAC inhibitory activities, and inhibitory activities on the growth of human cancer cell lines. Notably, one of these new derivatives, I , significantly restored RUNX3 in a dose-dependent manner and showed high metabolic stability, a good pharmacokinetic profile with high oral bioavailability and long half-life, and strong antitumor activity. This study suggests that pyridone-based analogs modulate RUNX3 activity through epigenetic regulation as well as strong transcriptional and post-translational regulation of RUNX3 and could be potential clin. candidates as orally available RUNX3 modulators for the treatment of cancer.

As far as I know, this compound(57825-30-6)Application of 57825-30-6 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 1-(Bromomethyl)-4-ethylbenzene, is researched, Molecular C9H11Br, CAS is 57825-30-6, about Convenient synthesis of [3R-(3α,4β,5α,6β)]-2-[7-chloro-1-(4-ethylbenzyl)-5-methyl-1H-indol-3-yl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, the main research direction is indolyl C glycoside preparation; indolylpyrantriol preparation.SDS of cas: 57825-30-6.

A novel and convenient approach for the preparation of [3R-(3α,4β,5α,6β)]-2-[7-chloro-1-(4-ethylbenzyl)-5-methyl-1H-indol-3-yl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol starting from 7-chloro-5-methylindole by three steps was developed. The product was achieved in 72% yield.

As far as I know, this compound(57825-30-6)SDS of cas: 57825-30-6 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

The reaction of an aromatic heterocycle with a proton is called a protonation. One of articles about this theory is 《Mechanism of aromatic side-chain reactions with special reference to the polar effects of substituents. IV. The mechanism of quaternary salt formation》. Authors are Baker, John W.; Nathan, Wilfred S..The article about the compound:1-(Bromomethyl)-4-ethylbenzenecas:57825-30-6,SMILESS:CCC1=CC=C(CBr)C=C1).Application of 57825-30-6. Through the article, more information about this compound (cas:57825-30-6) is conveyed.

cf. C. A. 29, 4657.5. The following data are given for the reaction of RC6H4CH2Br with C5H5N in dry Me2CO at the temperatures given, where R is: p-Me, 20°, 2.020 (kp × 104, g.-mol./l./sec.); 40°, 7.983; p-Et, 20°, 1.811; 30°, 3.517; 40°, 6.733; p-iso-Pr, 20°, 1.633; 40°, 6.500; p-tert-Bu, 20°, 1.652; 30°, 3.357; 40°, 6.467; 2,4-Me2, 20°, 6.287; 30°, 12.48; 40°, 24.05; 2,4-(NO2)2, 20°, 2.288; 30°, 4.700; 40°, 8.960. The results show that the small retarding effect of a p-NO2 group is replaced by an accelerating effect when a 2nd NO2 group is introduced into the 2-position. In a series of substituents arranged in order of decreasing +I or increasing -I effects, a min. velocity is found with the p-NO2 compound: 2,4-Me2 > (p-tert-Bu < p-iso-Pr < p-Et < p-Me) > H > p-NO2 ≪ 2,4-(NO2)2. The position of the 2,4-(NO2)2 group illustrates a new phenomenon, viz., the occurrence of a min. velocity in a graded polar series without change in reaction kinetics. The interaction of the 2,4-dinitrobenzyl bromide with C5H5N is strictly bimol., the velocity coefficient in Me2CO at 40° being independent of the concentration The accelerating effect of the 2,4-(NO2)2 groups observed in dry Me2CO is almost absent in aqueous 90% Me2CO and becomes a retarding effect in aqueous 90% EtOH. The results thus far show (1) the reaction between benzyl halides and tert-bases in non-aqueous media is strictly bimol. and involves a simultaneous addition and dissociation; the Arrhenius energy of activation E is, within exptl. error, unaffected by substituents and is closely related to the energy changes involved in the electron cycle as a whole; the velocity of the reaction, as affected by substituent groups in the aryl bromide, is determined mainly by some factor which is incorporated in the term P of the equation kp = PZe-E/RT; electron accession toward the side chain (+I effect) increases the reaction velocity; up to a point (at p-NO2), decrease of electron availability in the side chain decreases the velocity, but greater electron recession (in 2,4-(NO2)2) from the side chain to the nucleus reverses this effect and greatly increases the velocity. 2,4-Dinitrobenzylpyridinium bromide, m. 196° (decomposition). p-Ethylbenzyl bromide, b0.8 84°, m. 14.5-5.2°, from the chloride and NaBr in 90% aqueous Me2CO; iso-Pr homolog, b0.4 75°; tert-Bu homolog, b0.3 99°, m. 15.1°; 2,4-dimethylbenzyl bromide, b1.2 79°, m. 15°.

As far as I know, this compound(57825-30-6)Application of 57825-30-6 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Related Products of 217192-22-8. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: (4-(Pyridin-4-yl)phenyl)methanol, is researched, Molecular C12H11NO, CAS is 217192-22-8, about In situ-prepared homogeneous supramolecular organic framework drug delivery systems (sof-DDSs): Overcoming cancer multidrug resistance and controlled release. Author is Tian, Jia; Yao, Chi; Yang, Wen-Lin; Zhang, Lei; Zhang, Dan-Wei; Wang, Hui; Zhang, Fan; Liu, Yi; Li, Zhan-Ting.

Water-soluble three-dimensional porous supramol. organic frameworks (SOFs) have been demonstrated as a new generation of homogeneous polycationic platforms for anti-cancer drug delivery. The new SOF drug delivery systems (sof-DDSs) can adsorb dianionic pemetrexed (PMX), a clin. used chemotherapeutic agent instantaneously upon dissolving in water, which is driven by both electrostatic attraction and hydrophobicity. The in situ-prepared PMX@SOFs are highly stable and can avoid important release of the drug during plasm circulation and overcome the multidrug resistance of human breast MCF-7/Adr cancer cells to enter the cancer cells. Acidic microenvironment of cancer cells promotes the release of the drug in cancer cells. Both in vitro and in vivo studies have revealed that sof-DDSs considerably improve the treatment efficacy of PMX, leading to 6-12-fold reduction of the IC50 values, as compared with that of PMX alone. The new drug delivery strategy omits the loading process required by most of reported nanoparticle-based delivery systems and thus holds promise for future development of low-cost drug delivery systems.

As far as I know, this compound(217192-22-8)Related Products of 217192-22-8 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

HPLC of Formula: 57825-30-6. Aromatic heterocyclic compounds can also be classified according to the number of heteroatoms contained in the heterocycle: single heteroatom, two heteroatoms, three heteroatoms and four heteroatoms. Compound: 1-(Bromomethyl)-4-ethylbenzene, is researched, Molecular C9H11Br, CAS is 57825-30-6, about Chloromethylation of Aromatic Compounds Catalyzed by Surfactant Micelles in Oil-Water Biphasic System. Author is Liu, Qifa; Wei, Wei; Lu, Ming; Sun, Feng; Li, Jiang; Zhang, Yuchao.

In this work, the chloromethylation reaction of aromatic compounds was performed successfully by micellar catalysis in oil/water biphasic system at high reactant loadings that exceeded the solubilization capacity of micellar solutions The effects of cationic, nonionic and anionic surfactants on the reaction were compared. The mechanism of chloromethylation reaction and the mechanism of micellar catalysis were investigated. The results show that the micellar catalysis is an effective way to realize the chloromethylation. The chloromethylation reaction consists of electrophilic substitution reaction and nucleophilic substitution reaction. Cationic surfactants, especially those containing longer hydrophobic carbon chain, are more effective. Selectivity for mono-chloromethylation was remarkably improved and regioselectivity was found to be dependent on the nature of the surfactant. Under the optimal reaction conditions, chloromethylation of isopropylbenzene could obtain 97.5% selectivity in mono-chloromethylation and 8.28 para/ortho selectivity ratio at 89.8% conversion. Good conversion and high selectivity in mono-chloromethylation were obtained.

As far as I know, this compound(57825-30-6)HPLC of Formula: 57825-30-6 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Related Products of 57825-30-6. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: 1-(Bromomethyl)-4-ethylbenzene, is researched, Molecular C9H11Br, CAS is 57825-30-6, about Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors. Author is Buchynskyy, Andriy; Gillespie, J. Robert; Hulverson, Matthew A.; McQueen, Joshua; Creason, Sharon A.; Ranade, Ranae M.; Duster, Nicole A.; Gelb, Michael H.; Buckner, Frederick S..

A phenotypic screen of a compound library for antiparasitic activity on Trypanosoma brucei, the causative agent of Human African Trypanosomiasis (HAT), led to the identification of N-(2-aminoethyl)-N-Ph benzamides as a starting point for hit-to-lead medicinal chem. Eighty two analogs were prepared, which led to the identification of a set of highly potent N-(2-aminoethyl)-N-benzyloxyphenyl benzamides with the most potent compound 73 having an in vitro EC50 = 0.001 μM. The compounds displayed drug-like properties when tested in a number of in vitro assays. Compound 73 was orally bioavailable and displayed good plasma and brain exposure in mice, cured 2 out of 3 mice infected with Trypanosoma brucei in acute model when dosed orally at 50 mg/kg once per day for 4 days. Given its potent antiparasitic properties and its ease of synthesis, compound 73 represents a potential lead for the development of drug to treat Human African Trypanosomiasis.

As far as I know, this compound(57825-30-6)Related Products of 57825-30-6 can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

Safety of (4-(Pyridin-4-yl)phenyl)methanol. The fused heterocycle is formed by combining a benzene ring with a single heterocycle, or two or more single heterocycles. Compound: (4-(Pyridin-4-yl)phenyl)methanol, is researched, Molecular C12H11NO, CAS is 217192-22-8, about Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag Isopropyl. Author is Iwamura, Ryo; Tanaka, Masayuki; Okanari, Eiji; Kirihara, Tomoko; Odani-Kawabata, Noriko; Shams, Naveed; Yoneda, Kenji.

EP2 receptor agonists are expected to be effective ocular hypotensive agents; however, it has been suggested that agonism to other EP receptor subtypes may lead to undesirable effects. Through medicinal chem. efforts, we identified a scaffold bearing a (pyridin-2-ylamino)acetic acid moiety as a promising EP2-selective receptor agonist. (6-((4-(Pyrazol-1-yl)benzyl)(pyridin-3-ylsulfonyl)aminomethyl)pyridin-2-ylamino)acetic acid 13ax (omidenepag, OMD) exerted potent and selective activity toward the human EP2 receptor (h-EP2). Low doses of omidenepag iso-Pr (OMDI), a prodrug of 13ax, lowered intraocular pressure (IOP) in ocular normotensive monkeys. OMDI was selected as a clin. candidate for the treatment of glaucoma.

As far as I know, this compound(217192-22-8)Safety of (4-(Pyridin-4-yl)phenyl)methanol can be applied in many ways, which is helpful for the development of experiments. Therefore many people are doing relevant researches.

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider